Chelsea Therapeutics Intl Ltd fka CHIP

[TP143]

Longer the silence, more confident I become.

I am no expert, but logic tells me that if a company was going to take a drug to market themselves they would have held the most positive CC you have ever heard the day after approval, trying to assure everyone they have the capacity to take on such a challenge.

Without this, buyout or partnership are the only options that make sense. I am surprised with every day without news that the PPS isn't creeping up toward the low end of the analyst price targets.